In summary, our data suggest that the MMTV-cortactin transgenic mice neither develop breast tumors nor accelerate MMTV-cyclin D1-induced mammary tumorigenesis on top of the causal MG tumors that arose in the aged FVB/N mice. This evidence concerns the gene CCND1 and breast neoplasm.